On February 19, 2025, the Board of Directors of Tronox Holdings plc (the “Company”) appointed Julie Beck as an independent Director, effective March 1, 2025.
On February 12, 2025, Sherice R. Torres informed the Board of Directors (the “Board”) of Advance Auto Parts, Inc. (the “Company”) that she would not be standing for re-election to the Board at the Company’s upcoming annual meeting of shareholders.
Appointed
David Sparacio
Executive Vice President and Chief Financial Officer
On February 18, 2025, ServisFirst Bancshares, Inc. (the “Company”) announced the appointment of David Sparacio, 54, as Executive Vice President and Chief Financial Officer of ServisFirst Bank (the “Bank”).
Ed Woodie, who was previously serving as Interim Chief Financial Officer, will continue to serve as the Company’s Senior Vice President and Controller, but no longer as Interim Chief Financial Officer effective as of March 10, 2025.
Rebecca Liebert, Ph.D. informed the Corteva, Inc. (the “Company”) Board of Directors (the “Board”) on February 13, 2025 that she intends to pursue other opportunities and, therefore, will resign from her position as a director on the Company’s Board effective February 28, 2025.
on February 17, 2025 the Board unanimously selected Thomas Gebhardt, age 64, to fill the vacancy in the class of directors to be elected at the 2026 annual meeting of shareholders created by Mr. Babe’s resignation.
will become the new Chief Executive Officer upon Mr. Moghadam’s retirement effective January 1, 2026.
Departed
Andrew Hykes
Director
Inari Medical, Inc.
Effective
2025-02-19
Filed
February 19, 2025, 6:59 PM ET
Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.
Departed
Robert K. Warner
Director
Inari Medical, Inc.
Effective
2025-02-19
Filed
February 19, 2025, 6:59 PM ET
Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.
Appointed
J. Andrew Pierce
Director
Inari Medical, Inc.
Effective
2025-02-19
Filed
February 19, 2025, 6:59 PM ET
the directors of Merger Sub as of immediately prior to the Effective Time, William E. Berry Jr. and J. Andrew Pierce, became the directors of the Surviving Corporation
Appointed
William E. Berry Jr.
Director
Inari Medical, Inc.
Effective
2025-02-19
Filed
February 19, 2025, 6:59 PM ET
the directors of Merger Sub as of immediately prior to the Effective Time, William E. Berry Jr. and J. Andrew Pierce, became the directors of the Surviving Corporation
Departed
Bill Hoffman
Director
Inari Medical, Inc.
Effective
2025-02-19
Filed
February 19, 2025, 6:59 PM ET
Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.
Departed
Jonathan Root
Director
Inari Medical, Inc.
Effective
2025-02-19
Filed
February 19, 2025, 6:59 PM ET
Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.
Departed
Donald Milder
Director
Inari Medical, Inc.
Effective
2025-02-19
Filed
February 19, 2025, 6:59 PM ET
Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.
Departed
Dana G. Mead, Jr.
Director
Inari Medical, Inc.
Effective
2025-02-19
Filed
February 19, 2025, 6:59 PM ET
Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.
Departed
Catherine Szyman
Director
Inari Medical, Inc.
Effective
2025-02-19
Filed
February 19, 2025, 6:59 PM ET
Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.
Departed
Cynthia Lucchese
Director
Inari Medical, Inc.
Effective
2025-02-19
Filed
February 19, 2025, 6:59 PM ET
Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.
Departed
Rebecca Chambers
Director
Inari Medical, Inc.
Effective
2025-02-19
Filed
February 19, 2025, 6:59 PM ET
Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.
each of Matthew Alty, John Hamilton, Tony Koblinski, Brian Raduenz and Stephen Twitty were appointed to the Board of Directors of the Company (the "Board").
each of Matthew Alty, John Hamilton, Tony Koblinski, Brian Raduenz and Stephen Twitty were appointed to the Board of Directors of the Company (the "Board").
each of Matthew Alty, John Hamilton, Tony Koblinski, Brian Raduenz and Stephen Twitty were appointed to the Board of Directors of the Company (the "Board").
each of Matthew Alty, John Hamilton, Tony Koblinski, Brian Raduenz and Stephen Twitty were appointed to the Board of Directors of the Company (the "Board").
each of Matthew Alty, John Hamilton, Tony Koblinski, Brian Raduenz and Stephen Twitty were appointed to the Board of Directors of the Company (the "Board").
The Board appointed the Company’s Chief Executive Officer, Barry Gosin, as Principal Executive Officer of the Company following Howard Lutnick’s confirmation as the 41st Secretary of Commerce and departure from the Company.
Howard Lutnick, Chairman of the Board of Directors (the “Board”) and Executive Chairman of Newmark, informed the Company that he has stepped down as Chairman of the Board and Executive Chairman of the Company, effective February 18, 2025, as a result of his confirmation by the United States Senate as the 41st Secretary of Commerce.
On February 18, 2025, the Board appointed Kyle Lutnick to serve as a member of the Board, effective February 18, 2025, for a term to expire at the earlier of the 2025 Annual Meeting of Stockholders of the Company, or until his successor is duly elected and qualified.
Howard Lutnick, Chairman of the Board of Directors (the “Board”) and Chief Executive Officer of BGC Group, Inc. (“BGC” or the “Company”), informed the Company that he has stepped down as Chairman of the Board and Chief Executive Officer of the Company, effective February 18, 2025
Howard Lutnick, Chairman of the Board of Directors (the “Board”) and Chief Executive Officer of BGC Group, Inc. (“BGC” or the “Company”), informed the Company that he has stepped down as Chairman of the Board and Chief Executive Officer of the Company, effective February 18, 2025
succeeding Michael O. Johnson, the Company’s current Chairman and Chief Executive Officer, who will concurrently transition to serve as the Company’s Executive Chairman.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.